Open AccessCyclin-dependent kinase inhibitor p21 and proliferative marker ki67 in colonic carcinoma
Author(s) -
Sanjay Kumar,
Neha Singh,
Sant Prakash Kataria,
Shruti Kandoi,
Meena Verma,
Ruchira Sen
Publication year - 2022
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - Slovenian
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_712_21
Subject(s) - grading (engineering) , colorectal cancer , immunostaining , malignancy , medicine , immunohistochemistry , pathology , ki 67 , lymph node , carcinoma , biopsy , oncology , cancer , biology , ecology
Tumor grade employed for colorectal cancer has long been based on the degree of differentiation, which is difficult to judge objectively. The aim of this study was to assess the immunohistochemical expression of p21 and ki67 and their correlation with the histological grading of colorectal carcinoma.